×

Register now for full access to all the content

First Name
Last Name
Company
Title
Country
Thank you for registering!
Error - something went wrong!

Joshua Schultz, VP Speaks on Adding Value Through Strategic Partnerships

November 21, 2012
Josh talks about the value of strategic partnerships between biopharmaceutical companies and PAREXEL. He goes into detail about the three major value drivers: increasing the speed of development, reducing oversight while maintaining quality, and the reducing the overall total cost of ownership.
Previous Video
Drug Development Trends in Asia Pacific with Albert Liou, Vice Chairman
Drug Development Trends in Asia Pacific with Albert Liou, Vice Chairman

Albert Liou, Vice Chairman of Asia Pacific PAREXEL International, goes over the latest trends in drug devel...

Next Video
Alberto Grignolo, PhD Speaks on Regulatory Landscape in Japan Over the Next 5 Years
Alberto Grignolo, PhD Speaks on Regulatory Landscape in Japan Over the Next 5 Years

Alberto Grignolo, PhD speaks on the regulatory landscape in Japan over the next 5 years. He talks about the...